CrawlingA developer of non-invasive interface technology for brain computer, and Pupil Labs, a company involved in Eye-Tracking technology, entered into a strategic partnership to develop an interface that measures visual attention and neural signals.
The goal is for the EYE tracking software from Pupil Labs to connect to the AXON-R SDK interface from Cognixion, which makes it possible to make smooth data collection over platforms.
“High accurate eye tracking and advanced BCI [brain-computer interface] Electrical encephallogram capacities will give clinical researchers powerful new tools for neuroscience, interaction between people and computer and assistant technology research, “the companies said in a joint explanation.
Of the two technologies, they are expected to offer a higher level of data confidence and a platform that can adapt to the needs of patients, in particular patients with diseases, such as Amyotrophe Lateral Sclerosis (ALS), where progression can influence the power of the eye viewer.
According to Cogixion, the integrated tool researchers will enable prototypes and implement studies that simultaneously measure eye movements and brain activity, using the use of research sensors for both modalities without complicated technical integration.
It also offers access to synchronized data flows through a uniform developer interface, so that applications can be developed that respond to visual attention and neural signals.
Technical teams of the companies have started the integration process and the first releases are expected within six months.
“We are building an ecosystem around the Cognixion platform that speeds up innovation for clinical researchers, while our non -invasive technology enables us to considerably expand our market share,” said Andreas Forsland, CEO of Cognixion, said MobiHealthNews.
“Continuing the Axon-R platform from Cogixion with new technologies is an important part of our growth. As we continue to forge new collaborations, our technology becomes more exponentially more powerful when integrated with complementary solutions from industrial leaders.”
The larger trend
In May, Cogixion announced that Blackrock Neurotech, a company that implants BCIS, will offer the AXON-R Wearable Neural Interface platform from Cognixion to research institutions via its distribution network.
BlackRock Neurotech will act as an unlimited distributor of the Axon-R from Cognixion. This non -invasive portable device makes the precise measurement and modulation of brain activity possible through visual stimuli, biofeedback and neurofeedback.
Other companies involved in the brain-neural interface space include Neuralink, who implanted his brain computer interface in May in Brad Smith, a person who has ALS and is completely non-verbal; Smith can communicate with telepathy with the device.
Smith has released a video on X about his experience with Neuralink and how it works. The video is told with the help of a replica -generated replica of Smith’s voice cloned from earlier recordings, and Smith uses the BCI to control the mouse on his MacBook Pro to perform the story.
In March, Neuralink submitted applications to the American patent and Trademark Office (USPTO) to act the conditions “Telepathy”, “Blindsight” and “Telekinese”.
The applications relate to Neuralink’s first product, Telepathy, an interface of the brain computer that was aimed at enabling users to control devices with their thoughts; Blindsight, an implant that wants to restore the vision to people who are blind; And Telekinese, a term Elon Musk, the founder of the company has used interchangeably with telepathy with regard to controlling devices using a person’s mind.
#Cogixion #Pupil #Labs #Partner #EyeTracking #Interface